Dos Santos Haber Jesselina Francisco, Barbalho Sandra Maria, Sgarbi Jose Augusto, de Argollo Haber Rafael Santos, de Labio Roger William, Laurindo Lucas Fornari, Chagas Eduardo Federighi Baisi, Payão Spencer Luiz Marques
School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília 17525-160, Brazil.
Postgraduate Program of Health and Aging, Marilia Medical School (FAMEMA), Monte Carmelo, 800-Fragata, Marília 17519-030, Brazil.
Biomedicines. 2023 Apr 7;11(4):1120. doi: 10.3390/biomedicines11041120.
Type 1 diabetes mellitus (T1DM) is one of the major chronic diseases in children worldwide. This study aimed to investigate interleukin-10 (IL-10) gene expression and tumor necrosis factor-alpha (TNF-α) in T1DM. A total of 107 patients were included, 15 were T1DM in ketoacidosis, 30 patients had T1DM and HbA1c ≥ 8%; 32 patients had T1DM and presented HbA1c < 8%; and 30 were controls. The expression of peripheral blood mononuclear cells was performed using the reverse transcriptase-polymerase chain reaction in real time. The cytokines gene expression was higher in patients with T1DM. The IL-10 gene expression increased substantially in patients with ketoacidosis, and there was a positive correlation with HbA1c. A negative correlation was found for IL-10 expression and the age of patients with diabetes, and the time of diagnosis of the disease. There was a positive correlation between TNF-α expression with age. The expression of IL-10 and TNF-α genes showed a significant increase in DM1 patients. Once current T1DM treatment is based on exogenous insulin, there is a need for other therapies, and inflammatory biomarkers could bring new possibilities to the therapeutic approach of the patients.
1型糖尿病(T1DM)是全球儿童主要的慢性疾病之一。本研究旨在调查T1DM患者中白细胞介素-10(IL-10)基因表达及肿瘤坏死因子-α(TNF-α)情况。共纳入107例患者,其中15例为酮症酸中毒的T1DM患者,30例T1DM患者且糖化血红蛋白(HbA1c)≥8%;32例T1DM患者且HbA1c<8%;30例为对照。采用实时逆转录聚合酶链反应检测外周血单个核细胞的表达。T1DM患者细胞因子基因表达更高。酮症酸中毒患者IL-10基因表达显著增加,且与HbA1c呈正相关。发现IL-10表达与糖尿病患者年龄及疾病诊断时间呈负相关。TNF-α表达与年龄呈正相关。DM1患者IL-10和TNF-α基因表达显著增加。鉴于目前T1DM的治疗以使用外源性胰岛素为主,需要其他治疗方法,而炎症生物标志物可能为患者的治疗方法带来新的可能性。